|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1994-2-1
|
|
pubmed:abstractText |
To assess whether oral acyclovir can eliminate persistent Epstein-Barr virus (EBV) infection and thereby prevent EBV-associated lymphoma development in HIV-seropositive homosexual men.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1337-43
|
|
pubmed:dateRevised |
2009-9-29
|
|
pubmed:meshHeading |
pubmed-meshheading:8267906-Acyclovir,
pubmed-meshheading:8267906-Administration, Oral,
pubmed-meshheading:8267906-Adult,
pubmed-meshheading:8267906-Blotting, Southern,
pubmed-meshheading:8267906-Burkitt Lymphoma,
pubmed-meshheading:8267906-HIV Seropositivity,
pubmed-meshheading:8267906-Herpesviridae Infections,
pubmed-meshheading:8267906-Herpesvirus 4, Human,
pubmed-meshheading:8267906-Homosexuality,
pubmed-meshheading:8267906-Humans,
pubmed-meshheading:8267906-Male,
pubmed-meshheading:8267906-Oropharynx,
pubmed-meshheading:8267906-Tumor Virus Infections
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Epstein-Barr virus infection of HIV-seropositive individuals is transiently suppressed by high-dose acyclovir treatment.
|
|
pubmed:affiliation |
Department of Clinical Sciences, London School of Hygiene and Tropical Medicine, UK.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
